Why It Took So Long to Finally Get an RSV Vaccine

Respiratory syncytial virus (RSV) can dangerously compromise breathing, especially for infants and the elderly. But there has been no vaccine to prevent it—until today. On May 3, the U.S. Food and Drug Administration (FDA) approved the first vaccine against RSV, from GlaxoSmithKline (GSK), to prevent respiratory disease in people ages 60 and older. The Centers … Read more

To Make a Real Difference in Health Care, AI Will Need to Learn Like We Do

Millions of people, many of whom have never thought much about computer science, are experimenting with generative AI models such as the eminently conversational ChatGPT and creative image generator DALL-E. While these products reflect less of a technological breakthrough than AI’s emergence into the public consciousness, the traction they have found is guiding massive investment … Read more

Eli Lilly’s Alzheimer’s Drug Shows Greatest Benefit Yet

In a May 3 press release, Eli Lilly announced encouraging results from its latest study of its Alzheimer’s drug candidate, donanemab. In the Phase 3 study, which included more than 1,000 people with early signs of Alzheimer’s disease, people receiving donanemab experienced 35% slower cognitive decline, as measured on cognitive tests, than people receiving placebo. … Read more

Here’s How Long COVID-19 Vaccine Immunity Really Lasts

Whether you get it from a vaccine or an infection, COVID-19 immunity does not last forever. In a study published May 3 in JAMA Network Open, researchers combed through studies to determine just how long protection from the shots endures. The scientists, led by a team from Italy, analyzed 40 studies that documented people’s vaccination … Read more